TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Evolan Pharma AB
Closing information (x1000 DKK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 492,434 | 486,219 | 402,756 |
Financial expenses | 1,178 | 981 | 2,642 |
Earnings before taxes | 156,285 | 141,740 | 90,438 |
EBITDA | 204,898 | 192,709 | 141,032 |
Total assets | 577,000 | 401,584 | 311,715 |
Current assets | 328,876 | 257,287 | 185,200 |
Current liabilities | 142,833 | 111,300 | 111,498 |
Equity capital | 352,490 | 265,940 | 168,425 |
- share capital | 67 | 73 | 74 |
Employees (average) | 27 | 27 | 27 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 61.1% | 66.2% | 54.0% |
Turnover per employee | 18,238 | 18,008 | 14,917 |
Profit as a percentage of turnover | 31.7% | 29.2% | 22.5% |
Return on assets (ROA) | 27.3% | 35.5% | 29.9% |
Current ratio | 230.3% | 231.2% | 166.1% |
Return on equity (ROE) | 44.3% | 53.3% | 53.7% |
Change turnover | 45,599 | 91,087 | 76,329 |
Change turnover % | 10% | 23% | 23% |
Chg. No. of employees | 0 | 0 | 1 |
Chg. No. of employees % | 0% | 0% | 4% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.